Wednesday, November 13, 2024

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion

Must read



Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to heat up.



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article